Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
patent litigation
Pharma
Halozyme sues Merck over subcutaneous Keytruda
Halozyme alleges in a lawsuit that a subcutaneous formulation of Merck’s popular cancer drug Keytruda infringes 15 of its patents.
Angus Liu
Apr 24, 2025 2:41pm
Sun Pharma beats Incyte in appeals, teeing up US alopecia launch
Apr 10, 2025 10:00am
GSK, Pfizer end RSV patent feud amid vaccine market uncertainty
Apr 4, 2025 10:55am
Roche settles UPenn patent lawsuit over breast cancer drugs
Mar 14, 2025 3:00pm
In high-stakes patent fight, Moderna and Pfizer trade blows
Mar 6, 2025 10:52am
Amgen fends off Celltrion's proposed Prolia biosim until June
Jan 28, 2025 11:46am
